191 related articles for article (PubMed ID: 30910370)
1. Oxalosis Associated With High-Dose Vitamin C Ingestion in a Peritoneal Dialysis Patient.
D'Costa MR; Winkler NS; Milliner DS; Norby SM; Hickson LJ; Lieske JC
Am J Kidney Dis; 2019 Sep; 74(3):417-420. PubMed ID: 30910370
[TBL] [Abstract][Full Text] [Related]
2. Secondary oxalosis due to excess vitamin C intake: a cause of graft loss in a renal transplant recipient.
Yaich S; Chaabouni Y; Charfeddine K; Zaghdane S; Kharrat M; Kammoun K; Makni S; Boudawara T; Hachicha J
Saudi J Kidney Dis Transpl; 2014 Jan; 25(1):113-6. PubMed ID: 24434393
[TBL] [Abstract][Full Text] [Related]
3. Long-term, low-dose, intravenous vitamin C leads to plasma calcium oxalate supersaturation in hemodialysis patients.
Canavese C; Petrarulo M; Massarenti P; Berutti S; Fenoglio R; Pauletto D; Lanfranco G; Bergamo D; Sandri L; Marangella M
Am J Kidney Dis; 2005 Mar; 45(3):540-9. PubMed ID: 15754276
[TBL] [Abstract][Full Text] [Related]
4. Plasma calcium oxalate supersaturation in children with primary hyperoxaluria and end-stage renal failure.
Hoppe B; Kemper MJ; Bökenkamp A; Portale AA; Cohn RA; Langman CB
Kidney Int; 1999 Jul; 56(1):268-74. PubMed ID: 10411702
[TBL] [Abstract][Full Text] [Related]
5. Oxalobacter formigenes treatment combined with intensive dialysis lowers plasma oxalate and halts disease progression in a patient with severe infantile oxalosis.
Pape L; Ahlenstiel-Grunow T; Birtel J; Krohne TU; Hoppe B
Pediatr Nephrol; 2020 Jun; 35(6):1121-1124. PubMed ID: 32107618
[TBL] [Abstract][Full Text] [Related]
6. Secondary oxalosis: a cause of delayed recovery of renal function in the setting of acute renal failure.
Alkhunaizi AM; Chan L
J Am Soc Nephrol; 1996 Nov; 7(11):2320-6. PubMed ID: 8959621
[TBL] [Abstract][Full Text] [Related]
7. The clinical significance of assessment of serum calcium oxalate saturation in the hyperoxaluria syndromes.
Marangella M; Vitale C; Petrarulo M; Linari F
Nephrol Dial Transplant; 1995; 10 Suppl 8():11-3. PubMed ID: 8592617
[TBL] [Abstract][Full Text] [Related]
8. Vitamin C overload may contribute to systemic oxalosis in children receiving dialysis.
Kennedy SS; Perilloux A; Pereira RC; Handelman G; Wesseling-Perry K; Salusky IB
Pediatr Nephrol; 2021 Feb; 36(2):435-441. PubMed ID: 32772326
[TBL] [Abstract][Full Text] [Related]
9. Retinal oxalosis. A clinicopathologic report.
Wells CG; Johnson RJ; Qingli L; Bunt-Milam AH; Kalina RE
Arch Ophthalmol; 1989 Nov; 107(11):1638-43. PubMed ID: 2818286
[TBL] [Abstract][Full Text] [Related]
10. Thresholds of serum calcium oxalate supersaturation in relation to renal function in patients with or without primary hyperoxaluria.
Marangella M; Cosseddu D; Petrarulo M; Vitale C; Linari F
Nephrol Dial Transplant; 1993; 8(12):1333-7. PubMed ID: 8159301
[TBL] [Abstract][Full Text] [Related]
11. Arthritis associated with calcium oxalate crystals in an anephric patient treated with peritoneal dialysis.
Rosenthal A; Ryan LM; McCarty DJ
JAMA; 1988 Sep; 260(9):1280-2. PubMed ID: 3404640
[TBL] [Abstract][Full Text] [Related]
12. Effects of ascorbic acid and pyridoxine supplementation on oxalate metabolism in peritoneal dialysis patients.
Shah GM; Ross EA; Sabo A; Pichon M; Reynolds RD; Bhagavan H
Am J Kidney Dis; 1992 Jul; 20(1):42-9. PubMed ID: 1621677
[TBL] [Abstract][Full Text] [Related]
13. Secondary oxalosis due to excess vitamin C intake.
Nasr SH; Kashtanova Y; Levchuk V; Markowitz GS
Kidney Int; 2006 Nov; 70(10):1672. PubMed ID: 17080154
[No Abstract] [Full Text] [Related]
14. Antioxidant status of patients on peritoneal dialysis: associations with inflammation and glycoxidative stress.
Sundl I; Roob JM; Meinitzer A; Tiran B; Khoschsorur G; Haditsch B; Holzer H; Winklhofer-Roob BM
Perit Dial Int; 2009; 29(1):89-101. PubMed ID: 19164258
[TBL] [Abstract][Full Text] [Related]
15. Relative hyperoxaluria, crystalluria and haematuria after megadose ingestion of vitamin C.
Auer BL; Auer D; Rodgers AL
Eur J Clin Invest; 1998 Sep; 28(9):695-700. PubMed ID: 9767367
[TBL] [Abstract][Full Text] [Related]
16. A Case of Oxalate Nephropathy: When a Single Cause Is Not Crystal Clear.
Marques S; Santos S; Fremin K; Fogo AB
Am J Kidney Dis; 2017 Nov; 70(5):722-724. PubMed ID: 28739328
[TBL] [Abstract][Full Text] [Related]
17. Think of oxalate when using ascorbate supplementation to optimize iron therapy in dialysis patients.
Canavese C; Marangella M; Stratta P
Nephrol Dial Transplant; 2008 Apr; 23(4):1463-4; author reply 1464. PubMed ID: 18029374
[No Abstract] [Full Text] [Related]
18. Vitamin C-induced oxalate nephropathy in a renal transplant patient related to excessive ingestion of cashew pseudofruit (Anacardium occidentale L.): a case report.
Moyses-Neto M; Brito BRS; de Araújo Brito DJ; Barros NDC; Dantas M; Salgado-Filho N; Costa RS; Silva GEB
BMC Nephrol; 2018 Oct; 19(1):265. PubMed ID: 30314464
[TBL] [Abstract][Full Text] [Related]
19. Reduction of plasma oxalate levels by oral application of Oxalobacter formigenes in 2 patients with infantile oxalosis.
Hoppe B; Dittlich K; Fehrenbach H; Plum G; Beck BB
Am J Kidney Dis; 2011 Sep; 58(3):453-5. PubMed ID: 21705122
[TBL] [Abstract][Full Text] [Related]
20. Plasma oxalate levels rise in hemodialysis patients despite increased oxalate removal.
Costello JF; Sadovnic MJ; Cottington EM
J Am Soc Nephrol; 1991 Jun; 1(12):1289-98. PubMed ID: 1912391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
